The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries

Vaccine

Volumn 26, Issue 13, 2008, Pages 1611-1615

  Jadhav, Suresh ^a   Datla, Mahima ^b   Kreeftenberg, Hans ^c   Hendriks, Jan ^c  

^a India Limited ^*  (India)

^b Biological E Limited   (India)

^c NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Acccess to technology; Combination vaccines; Developing countries; Hepatitis B; Hib conjugate; Technology transfer; Vaccines

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; DEVELOPING COUNTRY; DRUG MANUFACTURE; DRUG MARKETING; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INFECTION; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

DEVELOPING COUNTRIES; DRUG INDUSTRY; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFLUENZA VACCINES; INTERNATIONAL COOPERATION; VACCINES; VACCINES, COMBINED;

EID: 40249102981     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.034     Document Type: Article

References (16)

1. OECD. High level forum on medicines for neglected and emerging infectious diseases: policy coherence to enhance their availability. Noordwijk-Aan-Zee, The Netherlands, June 20-21, 2007. http://www.oecd.org/document/31/0,3343,en_2649_18532957_38202975_1_1_1_1,00.html [accessed August 10, 2007].
2. Poeloengan T., Raw I., Martinez L.H., and El-Abbadi M. Developing Country Vaccine Manufacturers Network (DCVMN), April 26-27, 2001, Bandung, Indonesia. Vaccine 20 3-4 (2001) 285-287
3. Developing Country Vaccine Manufacturers Network (DCVMN). Website: http://www.dcvmn.com/ [accessed August 10, 2007].
4. Milstien J., Batson A., and Meaney W. A systematic method for evaluating the potential viability of local vaccine producers. Vaccine 15 12-13 (1997) 1358-1363
5. Kreeftenberg JG, Hamidi A. Annex 5. Lessons learned in the transfer of Hib conjugate vaccine technology and the consequences for access to this vaccine in developing countries. In: WHO Meeting Report. Intellectual Property Rights and Vaccines in Developing Countries, April 19-20, 2004. WHO Document WHO/IVB/04.21. http://www.who.int/vaccines-documents/DocsPDF05/Dip-789-screen.pdf [accessed August 16, 2007].
6. Schneerson R., Barrera O., Sutton A., and Robbins J.B. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 152 2 (1980) 361-376
7. Schneerson R., Robbins J.B., Barrera O., Sutton A., Habig W.B., Hardegree M.C., et al. Haemophilus influenzae type b polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines. Prog Clin Biol Res 47 (1980) 77-94
8. Global Alliance for Vaccines and Immunization (GAVI). Alliance Progress Report; 2006. http://www.gavialliance.org/resources/2006_Progress_Report.pdf [accessed August 10, 2007].
9. Milstien J., Gaule P., and Kaddar M. Access to vaccine technologies in developing countries: Brazil and India. Vaccine 25 (2007) 7610-7619
10. Barder O. Vaccines for development. Center for Global Development Brief; 2006. http://www.cgdev.org/content/publications/detail/7366/ [accessed August 16, 2007].
11. Milstien J., and Kaddar M. Managing the effect of TRIPS on availability of priority vaccines. Bull World Health Organ 84 5 (2006) 360-365
12. Guimaraes R., da Rocha Carvalheiro J., and Degrave W. Health technology and innovation: a Brazilian experience. In: Burke A.M., and de Francisco A. (Eds). Monitoring financial flows for health research, (2005), Global Forum for Health Research, Geneva, Switzerland 47-56. http://www.globalforumhealth.org
13. WHO. WHA 2007 resolution 68.2 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. http://www.who.int/gb/ebwha/pdf_files/WHA60/A60_R28-en.pdf [accessed August 10, 2007].
14. WHO Global pandemic influenza action plan to increase vaccine supply, WHO/IVB/06.13, WHO/CDS/EPR/GIP/2006.1. http://www.who.int/csr/resources/publications/influenza/WHO_CDS_EPR_GIP_2006_1/en/index.html [accessed August 16, 2007].
15. WHO Press Release. WHO facilitates influenza vaccine technology transfer to developing countries, April 24, 2007. http://www.who.int/mediacentre/news/notes/2007/np18/en/index.html [accessed August 17, 2007].
16. Intergovernmental Working Group on Public Health, Innovation and Intellectual Property. Draft global strategy and plan of action on public health, innovation and intellectual property, WHO Document A/PHI/IGWG/2/2; 2007. http://www.who.int/gb/phi-igwg/phi2/PDF/PHI_IGWG2_2-en.pdf [accessed August 18, 2007].